Академический Документы
Профессиональный Документы
Культура Документы
1
Center for Integrative Chemical Biology & Drug Discovery
• Mission
– Dynamic interface between biology,
assay development & medicinal chemistry
– ‘Bridge the gap between basic scientific investigation & clinical research
supported by NCI to reinforce therapeutics discovery.’
• James Doroshow, MD (National Cancer Institute - CBC)
2
Visit us at www.pharmacy.unc.edu/cicbdd to learn more!
Acute Lymphoblastic Leukemia - Background
Graham, 2006. Clinical Cancer Research. Huang, 2009. Journal of Structural Biology. 6
Project Goals
7
Lemke & Rothlin, 2008. Nature Reviews: Immunology. Ashley, et al. 2002. Cell Signaling Technology, Inc.
Project Strategy
In-House Chemistry
Assay
Validation -Small Molecule Synthesis
-Computational Modeling
-Analytical Chemistry
Small Molecule Screening
-UNC-CICBDD Synthesized
-Kinase-Targeted Library
-Library of Pharmaceutically Actives
Hit Profiling
Cellular / In Vivo
&
Assays 8
Confirmation
Our Caliper LabChip Set-Up
9
Optimization of Reaction Components - Kinase Concentration
• Results
– Mer Kinase
• > 90% total conversion
• 1 nM = 30%
– Tyro3 Kinase
• > 90% total
• 625 pM = 30%
10
Optimization of Reaction Components - Kinase Concentration
• Axl
– First lot showed
consistently
decreased activity
compared to Mer &
Tyro3 kinases
• Axl
– First lot showed
consistently
decreased activity
compared to Mer &
Tyro3 kinases
– Second lot showed
greater activity similar
to other kinases
Velocity
Velocity
0.4 0.3
1 0.3
0.2
0.2
0.1 0.1
0 0.0 0.0
250 500 750 1000 1250 -0.1 250 500 750 1000 1250 250 500 750 1000 1250
-0.1
[ATP] µM [ATP] µM [ATP] µM
-1
Mer ATP Km Tyro3 ATP Km New Axl ATP Km
100 50 30
40
75
% Conversion
20
% Conversion
% Conversion
30
50
20 10
25 10
0 0
0 10 20 30 40 50 60 70
10 20 30 40 50 60 70
10 20 30 40 50 60 70
-10 Time (minutes) 13
-25 Time (minutes) Time (minutes) -10
Optimization of Reaction Components – Caliper Protocol
• Standard protocol
dictated by Caliper
fluorescent peptide
substrate utilized
• Slight increase in
post-buffer sip time
resulted in better
resolution of
individual peaks
14
Optimization of Reaction Components - Troubleshooting
60
% Conversion
Fresh 1X Thaw 4X Thaw R2 = .986
40
20
0
0 1 2 3 4 5
Hours 15
Optimization of Reaction Components - Troubleshooting
• Protease Contamination
• Phosphatase Contamination
– Decreased signal observed within first 3 hours of reaction
Axl Titrat
1 Hour
16
14
12
10
6 2 Hours
4
-2
0 500 1000 1500 2000 2500 3000 3500 4000 3 Hours
[Axl] u
17
Optimization of Reaction Components - Troubleshooting
2hr
5hr
% Control Conversion
80 Tyro3
– Titration performed from Axl
10% → 0.01% 60
00
01
02
04
08
16
32
64
25
50
10 0
0
0
.0
• Staurosporine Inhibition
0.
0.
0.
0.
0.
0.
0.
0.
1.
2.
5.
% DMSO
% Conversion
20 15
% Conversion
IC50= 3nM 30
IC50=13nM IC50=109 nM
15
10
20
10
10 5
5
-6 -4 -2 0 2 4
-6 -4 -2 2 4 -6 -4 -2 0 2 4
-5
Log[Staurosporine] Log[Staurosporine] Log[Staurosporine] 19
Optimization of Reaction Components – Repeats for New Lots
Mer Tyro3
Axl Titration
40
100 60
80
% Conversion 30
%Conversion
40
% Conversion
60 20
40
10 20
20
0
0 0
20 40 60 80 20 40 60 80
20 40 60 80
-20 Time (minutes) -10 Time (minutes)
Time (minutes)
-20
0.2
% C onversion
0.2 0.4
Velocity
Velocity
R2=.958 R2=.998 R2=.976
0.1 0.1
0.2
0.0
0.0
500 1000 1500 0.0 20
0 500 1000 1500 0 500 1000 1500
ATPµM [ATP] µM [ATP] µM
-0.1
Optimization of Reaction Components - Troubleshooting
• Enzyme Stability
Multidrop Combi
• Protease Contamination
21
Optimization of Reaction Components - Troubleshooting
1% BSA
• Enzyme Stability
• Protease Contamination
• Three days with two full plates of Max Signal, Min Signal, and
Inhibitor Dose Response Curves (or Mid-Range Signal).
– "Min" signal: Measures background signal. For assays this is signal when
controlled inhibitor is added to completely inactivated enzyme.
23
Assay Validation Results – Mer Kinase
Tyro3
24
Targeted Library Screening
• Virtual Screening
– In silico screening of a large pool of commercially available 25
compounds performed by Dmitri Kireev
In-House Compound Screening
MP470 Z’ = .951
• Additional compounds
generated using structure-
based & ligand-based
design Z’ =26.938
Initial Hits from Targeted Screen
27
Conclusions
29
References
• Huang, X., et al., Structural insights into the inhibited states of the Mer
receptor tyrosine kinase. J Struct Biol, 2009. 165(2): p. 88-96.
• Li, Y., et al., Axl as a potential therapeutic target in cancer: role of Axl in
tumor growth, metastatsis & angiogenesis. Oncogene 2009, E-Pub July 27
ahead of print.